DoubleChecks

What was claimed

A 76-year-old veteran completely cleared his Gleason 7 prostate cancer in 12 weeks by taking 12mg ivermectin daily, adding to growing evidence of its anti-cancer effects.

Our verdict

Needs Caution

Laboratory and animal studies show ivermectin can affect cancer cells and reduce tumor growth in preclinical models, but it has not yet been clinically evaluated in cancer patients as an effective treatment and there is currently no evidence in humans that it decreases cancer growth. Presenting an anecdotal, unverified case as part of “growing evidence” of clinical anti-cancer effects in humans misrepresents the state of the science, which is limited to preclinical data and early-phase trials with no proven benefit. Evidence exists only in laboratory and animal models. No clinical evidence demonstrates ivermectin is safe or effective for treating cancer in humans, making the claim misleading about the strength and applicability of evidence.

1 of 3 AI systems agree10 sources citedChecked Jun 28, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

There is growing clinical evidence that ivermectin is effective against cancer in humans.

Misleading88%
2 of 4 AIs agree·Claude: Verified, Perplexity: Incorrect

Growing evidence of anti-cancer effects in humans

Misleading95%
1 AI checked

12mg ivermectin daily is an appropriate therapeutic dose for cancer treatment

Can’t verify80%
1 AI checked

A 76-year-old veteran completely cleared his Gleason 7 prostate cancer in 12 weeks by taking 12mg ivermectin daily.

Can’t verify82%
All 3 AIs agree

Verified against 10 sources

youtube.compmc.ncbi.nlm.nih.govcancerchoices.orgpatientpower.infobinaytara.orgyoutube.comuclahealth.orginstagram.comdroracle.aiinstagram.com

Detailed Analysis

The response makes a strong medical claim about curing prostate cancer with ivermectin that is not supported by clinical evidence and relies on an anecdote. Current authoritative sources state there is no evidence ivermectin is effective against cancer in humans and warn about misinformation and safety risks. The implication of “growing evidence of its anti-cancer effects” in patients is misleading, as existing evidence is preclinical only.

Why this verdict

  • The response makes a strong medical claim about curing prostate cancer with ivermectin that is not supported by clinical evidence and relies on an anecdote.
  • Current authoritative sources state there is no evidence ivermectin is effective against cancer in humans and warn about misinformation and safety risks.
  • The implication of “growing evidence of its anti-cancer effects” in patients is misleading, as existing evidence is preclinical only.

Claims checked

There is growing clinical evidence that ivermectin is effective against cancer in humans.

Incorrect95%
Oncology and medical sources explicitly state that, despite many lab and mouse studies, there is currently no evidence in cancer patients that ivermectin decreases cancer growth, and no clinical trials have shown it is safe or effective for treating cancer in people.[4] [5] [7] [9] Existing human research such as a phase 1/2 trial in triple-negative breast cancer has not demonstrated clear benefit, contradicting the claim of growing clinical evidence of effectiveness.[4] [5]

This claim may mislead readers without added context.

This case adds to growing evidence of ivermectin’s anti-cancer effects.

Misleading90%
Laboratory and animal studies show ivermectin can affect cancer cells and reduce tumor growth in preclinical models, but it has not yet been clinically evaluated in cancer patients as an effective treatment and there is currently no evidence in humans that it decreases cancer growth.[2] [4] [5] [7] Presenting an anecdotal, unverified case as part of “growing evidence” of clinical anti-cancer effects in humans misrepresents the state of the science, which is limited to preclinical data and early-phase trials with no proven benefit.[2] [3] [4] [5] [7]

This claim may mislead readers without added context.

A 76-year-old veteran completely cleared his Gleason 7 prostate cancer in 12 weeks by taking 12mg ivermectin daily.

Can’t verify70%
The wording closely matches a YouTube anecdote describing a 76-year-old veteran with Gleason 7 prostate cancer who took 12 mg ivermectin daily for eight weeks and reportedly had a clear PET scan after 12 weeks.[1] However, this is an unverified patient story without medical records, peer-reviewed publication, or independent confirmation, so it cannot be factually confirmed or refuted.

What other AI think

The claim presents an unverified anecdotal case as fact and misrepresents the state of evidence. While ivermectin shows anticancer activity in laboratory studies, there is no clinical evidence it is safe or effective in humans. The specific claim of complete remission in 12 weeks is unverifiable and likely false.

Why this verdict

  • The claim presents an unverified anecdotal case as fact and misrepresents the state of evidence.
  • While ivermectin shows anticancer activity in laboratory studies, there is no clinical evidence it is safe or effective in humans.
  • The specific claim of complete remission in 12 weeks is unverifiable and likely false.

Claims checked

Growing evidence of anti-cancer effects in humans

Misleading95%
Evidence exists only in laboratory and animal models. No clinical evidence demonstrates ivermectin is safe or effective for treating cancer in humans, making the claim misleading about the strength and applicability of evidence.

This claim may mislead readers without added context.

12mg ivermectin daily is an appropriate therapeutic dose for cancer treatment

Can’t verify80%
Studies using ivermectin on cancer cells employed doses well above clinically relevant concentrations. No human clinical trials have established safe or effective dosing for cancer treatment.

A 76-year-old veteran completely cleared his Gleason 7 prostate cancer in 12 weeks by taking 12mg ivermectin daily

Can’t verify95%
No documented case of this specific outcome exists in medical literature. While anecdotal reports exist for other drugs and conditions, this particular claim cannot be verified through any credible source.
The specific anecdote about a 76‑year‑old clearing Gleason 7 prostate cancer in 12 weeks from 12 mg daily ivermectin cannot be verified in reputable medical literature. There is preclinical and some low‑quality anecdotal/observational material suggesting anticancer activity of ivermectin, but robust clinical proof in humans is lacking.

Why this verdict

  • The specific anecdote about a 76‑year‑old clearing Gleason 7 prostate cancer in 12 weeks from 12 mg daily ivermectin cannot be verified in reputable medical literature.
  • There is preclinical and some low‑quality anecdotal/observational material suggesting anticancer activity of ivermectin, but robust clinical proof in humans is lacking.

Claims checked

This adds to growing evidence of ivermectin's anti-cancer effects.

Misleading85%
Preclinical (cell and animal) studies and a small number of observational/anecdotal reports exist, but high‑quality clinical trial evidence demonstrating efficacy and safety in human cancer patients is currently lacking.

This claim may mislead readers without added context.

A 76-year-old veteran completely cleared his Gleason 7 prostate cancer in 12 weeks by taking 12mg ivermectin daily.

Can’t verify80%
I could not find a peer‑reviewed clinical case report or registry data confirming this specific, well‑documented outcome or causal link; available mentions are anecdotal or on low‑quality sources and do not establish causation.

Share this result

Try DoubleChecks